| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Thursday’s Close |
|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | $139.96 | $375.48B | N/A |
Prescription for Success?
https://www.fool.com/investing/2019/04/23/prescription-for-success.aspx?source=iedfolrf0000001
Apr 23, 2019 - Prescription drug sales, the future of Hulu, and more.
0
Why This Could Be the Most Dangerous Time Ever to Invest in Healthcare Stocks
https://www.fool.com/investing/2019/04/30/why-this-could-be-the-most-dangerous-time-ever-for.aspx?source=iedfolrf0000001
Apr 30, 2019 - There's a clear and present danger to many healthcare stocks that's more serious than anything ever before. Here's what you need to know.
0
Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs
http://www.zacks.com/stock/news/415516/pharma-stock-roundup-fda-okays-line-extensions-of-lly-pfe-abbv-cancer-drugs?cid=CS-ZC-FT-415516
May 17, 2019 - FDA grants approval for line extensions of Lilly (LLY), Pfizer (PFE) and Roche (RHHBY)/AbbVie's (ABBV) cancer drugs
0
AbbVie's Brain Cancer Candidate Fails in Phase III Study
http://www.zacks.com/stock/news/416716/abbvies-brain-cancer-candidate-fails-in-phase-iii-study?cid=CS-ZC-FT-416716
May 20, 2019 - AbbVie's (ABBV) phase III study on Depatux-M, an investigational candidate for newly diagnosed glioblastoma, fails to show survival benefit in patients receiving Depatux-M.
0
Dow 30 Stock Roundup: Home Depot Earnings Impress, Merck to Buy Peloton Therapeutics
http://www.zacks.com/stock/news/418993/dow-30-stock-roundup-home-depot-earnings-impress-merck-to-buy-peloton-therapeutics?cid=CS-ZC-FT-418993
May 24, 2019 - The index suffered a difficult week as investors braced for a protracted U.S.-China trade war.
0
This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy
https://www.fool.com/investing/2019/05/28/this-just-in-goldman-sachs-picks-4-big-pharma-stoc.aspx?source=iedfolrf0000001
May 28, 2019 - And the analyst really likes one in particular.
0
Allergan's (AGN) Vraylar Gets FDA Nod for Bipolar Depression
http://www.zacks.com/stock/news/421714/allergans-agn-vraylar-gets-fda-nod-for-bipolar-depression?cid=CS-ZC-FT-421714
May 29, 2019 - Allergan's (AGN) sNDA for Vraylar gets the FDA approval for the treatment of adult patients with major depressive episodes related to bipolar I disorder.
0
Pharma Stock Roundup: ASCO Update, FDA Nod for LLY's Emgality for Cluster Headache
http://www.zacks.com/stock/news/426292/pharma-stock-roundup-asco-update-fda-nod-for-llys-emgality-for-cluster-headache?cid=CS-ZC-FT-426292
Jun 07, 2019 - Pharma bigwigs present data from cancer studies at ASCO. Lilly's (LLY) CGRP Emgality gets FDA approval for episodic cluster headache in adults.
0
Pharma Stock Roundup: MRK Buys Small Cancer Biotech, RHHBY, MRK Drugs Get FDA Nod
http://www.zacks.com/stock/news/429560/pharma-stock-roundup-mrk-buys-small-cancer-biotech-rhhby-mrk-drugs-get-fda-nod?cid=CS-ZC-FT-429560
Jun 14, 2019 - Key developments of the week include Merck's (MRK) deal to buy Tilos Therapeutics and FDA approval for Roche's (RHHBY) polatuzumab vedotin and Merck's Keytruda.
0
Medidata (MDSO) to be Acquired by Dassault for $5.8 Billion
http://www.zacks.com/stock/news/429632/medidata-mdso-to-be-acquired-by-dassault-for-%2458-billion?cid=CS-ZC-FT-429632
Jun 14, 2019 - Dassault's acquisition of Medidata (MDSO) to close by 2019-end.
0
Page 1>